Allergic Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Allergic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 27 trials

Recruiting
Not Applicable

Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children

AnxietyAsthma (Diagnosis)Allergic Rhinitis+1 more
Antalya Training and Research Hospital100 enrolled1 locationNCT07453615
Recruiting
Phase 1Phase 2

Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma

Allergic AsthmaAllergic Rhinitis
University of Zurich36 enrolled1 locationNCT06960382
Recruiting

The Efficacy of Specific Immunotherapy Guided by Component-Resolved Diagnosis for Dust Mite Allergens in Chinese Pediatric Patients With Rhinitis and/or Asthma

Allergic Rhinitis Due to House Dust Mite
The Children's Hospital of Zhejiang University School of Medicine1,000 enrolled1 locationNCT07452380
Recruiting
Phase 2

Dupilumab Effects Against Aeroallergen Challenge

Asthma, Allergic
The University of Texas Health Science Center at San Antonio88 enrolled2 locationsNCT05720325
Recruiting
Phase 2

5HTP Regulation Of Asthma In Children

Mild or Moderate Asthma With Allergic Sensitization
Indiana University20 enrolled1 locationNCT04160910
Recruiting

ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

Chronic Spontaneous Urticaria (CSU)Allergic Asthma
Celltrion HealthCare France225 enrolled1 locationNCT07425639
Recruiting

Impact of Help-Seeking Behaviors on Allergic Rhinitis and Mental Health: A Longitudinal Study

Mental Health ConditionsAllergic
QHSLab, Inc.200,000 enrolled1 locationNCT06623799
Recruiting

Allergy and Immunology Natural History Study

Immune DeficiencyImmune Dysregulation DisorderAllergic Inflammation
Columbia University10,000 enrolled1 locationNCT05584488
Recruiting
Phase 2

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

Allergic Asthma
Oneness Biotech Co., Ltd.100 enrolled13 locationsNCT05008965
Recruiting
Phase 2

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

Allergic Asthma
Longbio Pharma200 enrolled1 locationNCT07342803
Recruiting
Phase 3

A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65

Allergic RhinitisAllergic Rhinoconjunctivitis
ALK-Abelló A/S300 enrolled30 locationsNCT07060885
Recruiting

A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up

Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a
National Institute of Allergy and Infectious Diseases (NIAID)10,000 enrolled1 locationNCT06732414
Recruiting
Phase 3

Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma

Perennial Allergic Rhinitis Accompanied by Asthma
Daewon Pharmaceutical Co., Ltd.274 enrolled1 locationNCT07168473
Recruiting
Not Applicable

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Allergic AsthmaAsthma AcuteThunderstorm Asthma+3 more
University of Melbourne530 enrolled1 locationNCT07055542
Recruiting

Evaluation of Nasal Biomarkers for Objective Assessment of Disease Severity in Respiratory Disorders

Healthy VolunteersChronic Obstructive Pulmonary Disease (COPD)Asthma Patients+7 more
Diag-Nose Medical Pty Ltd250 enrolled1 locationNCT06661252
Recruiting
Not Applicable

Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma

Mild Allergic Asthma
Fraunhofer-Institute of Toxicology and Experimental Medicine15 enrolled1 locationNCT06317909
Recruiting
Phase 3

Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites

Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.150 enrolled32 locationsNCT04435990
Recruiting
Phase 3

Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.

Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.180 enrolled27 locationsNCT04898283
Recruiting
Phase 3

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen

Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L.180 enrolled32 locationsNCT04891237
Recruiting
Phase 3

A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)

Allergic Asthma
Bridgette Jones300 enrolled1 locationNCT04699604